● Recruiting

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Single Ascending Doses of ABBV-1451 Infusions and Injections in Healthy Adult Participants

Condition: Healthy Volunteer · Sponsor: AbbVie

PhasePhase 1

Planned participants90

Who can joinAll sexes, 18 Years to 60 Years

Healthy volunteersYes

About this study

The objective of this study is to assess the pharmacokinetic (PK), immunogenicity, safety, and tolerability of ABBV-1451 after single ascending doses in healthy adult volunteers.

This description comes directly from the study's public registry record.

Talk to the study team

ABBVIE CALL CENTER · 844-663-3742 · abbvieclinicaltrials@abbvie.com

Always discuss trial participation with your own doctor first.

Locations (1)

Acpru /Id# 282128

Grayslake, Illinois, United States

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07570147